ROCKVILLE, Md., June 12, 2018 /PRNewswire/ -- The Health Resources and Services Administration (HRSA) will host health care officials from six nations ? Canada, Brazil, India, Rwanda, Finland and the United Kingdom ? as well as thought leaders from across the U.S. government and academia on June 19-21 for a three-day conference on maternal mortality. The HRSA Maternal Mortality Summit will examine challenges and seek innovative solutions to reduce maternal mortality in the United States and globally. Attendance is by invitation only. HRSA will provide a free, live webcast of the Summit's plenary sessions for the press and the public.
WHAT: HRSA Maternal Mortality Summit.
WHO: Experts from Brazil, Canada, Finland, India, Rwanda, United Kingdom, and the United States will participate. Scheduled speakers include Doris Chou from the World Health Organization and U.S. Surgeon General Jerome Adams.
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings.
SONIFI Health is a leading U.S. healthcare technology company based in Sioux...
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....
Hondros College of Nursing (HCN) will introduce a new Medical Assisting program at its six Ohio campuses in 2024 to meet the growing need for medical assistants in a variety of settings.
According to the U.S. Bureau of Labor Statistics (BLS),...
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services.
"Mahesh is a dynamic and...
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...